278 related articles for article (PubMed ID: 11193928)
1. Preclinical and clinical trials of topoisomerase inhibitors.
Saijo N
Ann N Y Acad Sci; 2000; 922():92-9. PubMed ID: 11193928
[TBL] [Abstract][Full Text] [Related]
2. FDA approves irinotecan as first-line therapy for colorectal cancer.
Oncology (Williston Park); 2000 May; 14(5):652, 654. PubMed ID: 10853457
[No Abstract] [Full Text] [Related]
3. Topoisomerase I inhibitors in small-cell lung cancer. The Japanese experience.
Saijo N; Horiike A
Oncology (Williston Park); 2004 Jun; 18(7 Suppl 4):11-6. PubMed ID: 15255163
[TBL] [Abstract][Full Text] [Related]
4. Role of topoisomerase I inhibitors in small-cell lung cancer.
Fukuoka M
Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):9-13. PubMed ID: 11497234
[TBL] [Abstract][Full Text] [Related]
5. [Clinical activity spectrum of irinotecan].
Cottu PH; Extra JM; Lerebours F; Espie M; Marty M
Bull Cancer; 1998 Dec; Spec No():21-5. PubMed ID: 9932080
[TBL] [Abstract][Full Text] [Related]
6. Irinotecan therapy for small-cell lung cancer.
Sandler A
Oncology (Williston Park); 2002 Apr; 16(4):419-25, 428, 433; discussion 433-4, 437-8. PubMed ID: 12017533
[TBL] [Abstract][Full Text] [Related]
7. 7-Ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxy camptothecin: mechanism of resistance and clinical trials.
Saijo N; Nishio K; Kubota N; Kanzawa F; Shinkai T; Karato A; Sasaki Y; Eguchi K; Tamura T; Ohe Y
Cancer Chemother Pharmacol; 1994; 34 Suppl():S112-7. PubMed ID: 8070019
[TBL] [Abstract][Full Text] [Related]
8. Irinotecan in advanced lung cancer: focus on North American trials.
Langer CJ
Oncology (Williston Park); 2004 Jun; 18(7 Suppl 4):17-28. PubMed ID: 15255164
[TBL] [Abstract][Full Text] [Related]
9. CPT-11: an original spectrum of clinical activity.
Rothenberg ML
Semin Oncol; 1996 Feb; 23(1 Suppl 3):21-6. PubMed ID: 8633249
[TBL] [Abstract][Full Text] [Related]
10. Clinical trials of irinotecan hydrochloride (CPT, campto injection, topotecin injection) in Japan.
Saijo N
Ann N Y Acad Sci; 1996 Dec; 803():292-305. PubMed ID: 8993523
[TBL] [Abstract][Full Text] [Related]
11. [Second-line irinotecan chemotherapy in the treatment of metastatic colorectal cancers: phase III trials].
Mitry E; Ducreux M; Rougier P
Bull Cancer; 1998 Dec; Spec No():38-42. PubMed ID: 9932083
[TBL] [Abstract][Full Text] [Related]
12. [Irinotecan].
Yokoyama A
Nihon Rinsho; 2002 May; 60 Suppl 5():339-42. PubMed ID: 12101684
[No Abstract] [Full Text] [Related]
13. [Irinotecan in colorectal cancer].
Pozzo C; Cassano A; Barone C
Tumori; 2001; 87(1 Suppl 1):S49-50. PubMed ID: 11300023
[No Abstract] [Full Text] [Related]
14. Irinotecan in the treatment of small cell lung cancer.
Masuda N; Fukuoka M
Expert Rev Anticancer Ther; 2001 Aug; 1(2):187-95. PubMed ID: 12113024
[TBL] [Abstract][Full Text] [Related]
15. The role of irinotecan in colorectal cancer.
Saltz LB
Curr Oncol Rep; 1999; 1(2):155-60. PubMed ID: 11122813
[TBL] [Abstract][Full Text] [Related]
16. [Irinotecan: various administration schedules, study of drug combinations, phase I experience].
Boige V; Raymond E; Armand JP
Bull Cancer; 1998 Dec; Spec No():26-32. PubMed ID: 9932081
[TBL] [Abstract][Full Text] [Related]
17. [Irinotecan-containing combinations in solid tumors, except colonic carcinomas].
Couteau C; Armand JP
Bull Cancer; 1998 Dec; Spec No():47-50. PubMed ID: 9932085
[TBL] [Abstract][Full Text] [Related]
18. Phase I study of sequentially administered topoisomerase I inhibitor (irinotecan) and topoisomerase II inhibitor (etoposide) for metastatic non-small-cell lung cancer.
Ando M; Eguchi K; Shinkai T; Tamura T; Ohe Y; Yamamoto N; Kurata T; Kasai T; Ohmatsu H; Kubota K; Sekine I; Hojo N; Matsumoto T; Kodama T; Kakinuma R; Nishiwaki Y; Saijo N
Br J Cancer; 1997; 76(11):1494-9. PubMed ID: 9400948
[TBL] [Abstract][Full Text] [Related]
19. Treatment of advanced or recurrent colorectal cancer with irinotecan in Japan and elsewhere.
Sato T; Hatate K; Ikeda A; Yamanashi T; Ozawa H; Onosato W; Nakamura T; Ihara A; Watanabe M
Expert Opin Pharmacother; 2008 May; 9(7):1223-8. PubMed ID: 18422478
[TBL] [Abstract][Full Text] [Related]
20. Topoisomerase I inhibitors in the treatment of colorectal cancer.
Rothenberg ML; Blanke CD
Semin Oncol; 1999 Dec; 26(6):632-9. PubMed ID: 10606256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
